Literature DB >> 15052405

[Pulmonary edema].

H A Ghofrani1.   

Abstract

An acute respiratory insufficiency as a result of pulmonary oedema is regarded as a life threatening emergency event. Diagnostic classification differentiates between cardiogenic and non-cardiogenic lung oedema. Symptomatic treatment of the impaired gas exchange often precedes a causal therapy of the underlying disease. For this purpose non-invasive ventilation, in parallel with efficient medical interventions, has come into focus. Moreover, this therapeutic intervention can prevent from the necessity of endotracheal intubation in the majority of cases. Rapid restoration of arterial oxygenation along with medical support of the cardiac function (i.e. by nitrates, diuretics, ACE-inhibitors, etc.) results in improved myocardial oxygen-delivery and reduced oxygen-consumption. This article reviews mainly the pathophysiology of cardiogenic lung edema, while most of the currently discussed therapeutic implications also apply to other entities of lung edema.

Entities:  

Mesh:

Year:  2004        PMID: 15052405     DOI: 10.1007/s00108-004-1175-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  16 in total

1.  Dopamine regulates NA,K-adenosine triphosphatase in alveolar epithelial cells via the mitogen-activated protein kinase/extracellular-signal-regulated kinase pathway.

Authors:  C Guerrero; A Ghosh; E Lecuona; K Ridge; E Santos; J I Sznajder
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

2.  Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial.

Authors:  J Masip; A J Betbesé; J Páez; F Vecilla; R Cañizares; J Padró; M A Paz; J de Otero; J Ballús
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

Review 3.  The problem of decompensated heart failure: nomenclature, classification, and risk stratification.

Authors:  G Michael Felker; Kirkwood F Adams; Marvin A Konstam; Christopher M O'Connor; Mihai Gheorghiade
Journal:  Am Heart J       Date:  2003-02       Impact factor: 4.749

Review 4.  Alveolar epithelial fluid transport: basic mechanisms and clinical relevance.

Authors:  M A Matthay; H R Flori; E R Conner; L B Ware
Journal:  Proc Assoc Am Physicians       Date:  1998 Nov-Dec

5.  Pulmonary epithelial permeability in ARDS and cardiogenic pulmonary oedema.

Authors:  T Todisco; M Dottorini; F Rossi; A Baldoncini; R Palumbo
Journal:  Eur Respir J       Date:  1988-12       Impact factor: 16.671

6.  Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  L Brochard; J Mancebo; M Wysocki; F Lofaso; G Conti; A Rauss; G Simonneau; S Benito; A Gasparetto; F Lemaire
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

Review 7.  Aquaporin water channels and lung physiology.

Authors:  A S Verkman; M A Matthay; Y Song
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-05       Impact factor: 5.464

8.  Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up.

Authors:  M Lin; Y F Yang; H T Chiang; M S Chang; B N Chiang; M D Cheitlin
Journal:  Chest       Date:  1995-05       Impact factor: 9.410

Review 9.  Management of acute decompensated heart failure in the emergency department.

Authors:  W Frank Peacock; John Allegra; Douglas Ander; Sean Collins; Deborah Diercks; Charles Emerman; J Douglas Kirk; Randall C Starling; Marc Silver; Richard Summers
Journal:  Congest Heart Fail       Date:  2003 Sep-Oct

Review 10.  Diastolic heart failure demystified.

Authors:  Philip Andrew
Journal:  Chest       Date:  2003-08       Impact factor: 9.410

View more
  1 in total

1.  [Retrospective analysis of 44 childhood drowning accidents].

Authors:  Caroline Brüning; Werner Siekmeyer; Manuela Siekmeyer; Andreas Merkenschlager; Wieland Kiess
Journal:  Wien Klin Wochenschr       Date:  2010-07-08       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.